Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease

Overview

Journal Crohns Colitis 360

Publisher Oxford University Press

Date 2023 Feb 17

PMID 36798512

Authors

Wael El-Matary

Affiliations

Soon will be listed here.

Citing Articles

Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines.

Looser R, Doulberis M, Rossel J, Franc Y, Muller D, Biedermann L Ann Gastroenterol. 2023; 36(6):637-645.

PMID: 38023976 PMC: 10662061. DOI: 10.20524/aog.2023.0832.

References

Ben-Horin S, Goldstein I, Fudim E, Picard O, Yerushalmi Z, Barshack I . Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines. Gut. 2008; 58(3):396-403. DOI: 10.1136/gut.2008.157339. View

El-Matary W . Indicators of Quality of Care in Inflammatory Bowel Disease: Seeking the Right Path for Patients. Inflamm Bowel Dis. 2017; 23(5):702-703. DOI: 10.1097/MIB.0000000000001069. View

Konidari A, Matary W . Use of thiopurines in inflammatory bowel disease: Safety issues. World J Gastrointest Pharmacol Ther. 2014; 5(2):63-76. PMC: 4023326. DOI: 10.4292/wjgpt.v5.i2.63. View

Derijks L, Gilissen L, Engels L, Bos L, Bus P, Lohman J . Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease. Ther Drug Monit. 2006; 28(1):45-50. DOI: 10.1097/01.ftd.0000179839.71138.6d. View

Lee J, Kim T, Ran Kim E, Hong S, Kyung Chang D, Choi L . Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn's disease. PLoS One. 2017; 12(12):e0188925. PMC: 5716599. DOI: 10.1371/journal.pone.0188925. View

Gisbert J, Gomollon F . Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review. Am J Gastroenterol. 2008; 103(7):1783-800. DOI: 10.1111/j.1572-0241.2008.01848.x. View

Hyams J, Dubinsky M, Baldassano R, Colletti R, Cucchiara S, Escher J . Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease. Gastroenterology. 2017; 152(8):1901-1914.e3. DOI: 10.1053/j.gastro.2017.02.004. View

Georgy M, Negm Y, El-Matary W . Quality improvement in healthcare for patients with inflammatory bowel disease. Transl Pediatr. 2019; 8(1):77-82. PMC: 6382498. DOI: 10.21037/tp.2019.01.02. View

French H, Dalzell A, Srinivasan R, El-Matary W . Relapse rate following azathioprine withdrawal in maintaining remission for Crohn's disease: a meta-analysis. Dig Dis Sci. 2011; 56(7):1929-36. DOI: 10.1007/s10620-011-1671-5. View

10.

Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R . A controlled double blind study of azathioprine in the management of Crohn's disease. Gut. 1995; 37(5):674-8. PMC: 1382873. DOI: 10.1136/gut.37.5.674. View

11.

Timmer A, McDonald J, Tsoulis D, MacDonald J . Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2012; (9):CD000478. DOI: 10.1002/14651858.CD000478.pub3. View

12.

Markowitz J, Grancher K, Kohn N, Lesser M, Daum F . A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology. 2000; 119(4):895-902. DOI: 10.1053/gast.2000.18144. View

13.

Diak P, Siegel J, La Grenade L, Choi L, Lemery S, McMahon A . Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum. 2010; 62(8):2517-24. DOI: 10.1002/art.27511. View

14.

Jonason D, Sievers T, Trocke L, Abraham J, Vaughn B . Normal Ranges of Thiopurine Methyltransferase Activity Do Not Affect Thioguanine Nucleotide Concentrations With Azathioprine Therapy in Inflammatory Bowel Disease. Crohns Colitis 360. 2023; 2(3):otaa058. PMC: 9802184. DOI: 10.1093/crocol/otaa058. View

15.

Konidari A, Anagnostopoulos A, Bonnett L, Pirmohamed M, El-Matary W . Thiopurine monitoring in children with inflammatory bowel disease: a systematic review. Br J Clin Pharmacol. 2014; 78(3):467-76. PMC: 4243898. DOI: 10.1111/bcp.12365. View